Qelbree (Viloxazine Hydrochloride)
100 mg/1 · Extended-Release Capsule
By Supernus Pharmaceuticals, Inc
Viloxazine Hydrochloride · Extended-Release Capsule · 100 mg
- NDC
- 17772-131
- Route
- Oral
- Therapeutic class
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2B6 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Norepinephrine Reuptake Inhibitor , Norepinephrine Uptake Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-07)NDC 17772-131-07Available to Order
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-30)NDC 17772-131-30Available to Order
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-60)NDC 17772-131-60Available to Order
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-90)NDC 17772-131-90Available to Order
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-131-01)NDC 17772-131-01Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs

